A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunityJonas S. Heitmann, Juliane S. Walz|Nature|2021Cited by 273
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Juliane S. Walz|Nature Communications|2022Cited by 73
Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with CancerTatjana Bilich, Juliane S. Walz|Cancer Discovery|2021Cited by 47
Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myelomaTatjana Bilich, Juliane S. Walz|Blood Cancer Journal|2020Cited by 21
Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose ChemotherapyMalte Roerden, Juliane S. Walz|Cancers|2021Cited by 2